[{"data":1,"prerenderedAt":47},["ShallowReactive",2],{"q-nurse-108-2-medical-surgical-038":3},{"subject":4,"subjectSlug":5,"subjectFullName":4,"question":6,"related":23},"內外科護理學","medical-surgical",{"id":7,"webId":8,"year":9,"session":10,"subject":4,"number":11,"stem":12,"options":13,"answer":18,"answerNote":19,"images":20,"explanation":21,"freq":22},"nurse-108-2-內外科護理學-038","nurse-108-2-medical-surgical-038",108,2,38,"下列何者屬於發疱劑（vesicant agent）的化學治療製劑？",{"A":14,"B":15,"C":16,"D":17},"ara-C","bleomycin","endoxan","oncovin","D",null,[],"本題考點是化學治療製劑中屬於發疱劑(vesicant)者的辨識。依藥物外滲毒性分類,發疱劑外滲會造成組織壞死與潰瘍,oncovin(vincristine,長春新鹼)屬典型植物鹼類發疱劑,故選 D。A ara-C(cytarabine)一般歸為非發疱性或刺激性,外滲毒性較低。B bleomycin 屬非發疱劑。C endoxan(cyclophosphamide)一般為非發疱劑或輕度刺激劑。考點在於記憶長春花鹼類與蒽環類為主要發疱劑,給藥時須確保靜脈通暢以防外滲壞死。",1,[24,28,31,35,39,43],{"webId":25,"stem":26,"number":22,"year":27,"session":22},"nurse-106-1-medical-surgical-001","有關巴金森氏病治療之敘述，下列何者正確？",106,{"webId":29,"stem":30,"number":10,"year":27,"session":22},"nurse-106-1-medical-surgical-002","有關巴金森氏病的護理指導，下列何者正確？",{"webId":32,"stem":33,"number":34,"year":27,"session":22},"nurse-106-1-medical-surgical-003","下列何者為出血性腦中風最主要的危險因子？",3,{"webId":36,"stem":37,"number":38,"year":27,"session":22},"nurse-106-1-medical-surgical-004","有關頸部脊髓損傷的神經性休克徵象，下列何者正確？",4,{"webId":40,"stem":41,"number":42,"year":27,"session":22},"nurse-106-1-medical-surgical-005","陳小姐診斷為腦下垂體腫瘤，進行經蝶骨腦下垂體切除術，術後出現尿崩症，下列敘述何者錯誤？",5,{"webId":44,"stem":45,"number":46,"year":27,"session":22},"nurse-106-1-medical-surgical-006","顱底骨折常出現的徵象，下列何者錯誤？",6,1783840759050]